Search results
5 days ago · Gilead Sciences Stock Down 0.3 %. Shares of NASDAQ:GILD opened at $68.40 on Wednesday. The firm has a market cap of $85.22 billion, a PE ratio of 190.00, a price-to-earnings-growth ratio of 2.92 ...
1 day ago · Norden Group LLC's holdings in Gilead Sciences were worth $885,000 as of its most recent SEC filing. Other large investors also recently modified their holdings of the company. Tompkins Financial Corp grew its position in Gilead Sciences by 223.1% in the third quarter. Tompkins Financial Corp now owns 349 shares of the biopharmaceutical company ...
12 hours ago · BNP Paribas acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 1st quarter, HoldingsChannel.com reports. The institutional investor acquired 78,605 shares of the biopharmaceutical company’s stock, valued at approximately $5,758,000. A number of other hedge funds have also modified their holdings of GILD. Tompkins Financial Corp lifted its holdings in […]
Jun 26, 2024 · Gilead Sciences, Inc Announces New Data Support the Use of BICtegravir Tablet Regimen to Treat People with HIV and Individuals with HIV/HBV-Coinfection in Asia CI Jun. 26: Redburn Atlantic Adjusts Price Target on Gilead Sciences to $119 From $117 MT
2 days ago · July 6, 2024. Sequoia Financial Advisors LLC reduced its holdings in shares of Gilead Sciences, Inc. ( NASDAQ:GILD - Free Report) by 11.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,854 shares of the biopharmaceutical company's stock after ...
4 days ago · Maintains. $82 → $85. +27.28%. Jan 23, 2024. Show More Ratings. A list of analyst ratings for Gilead Sciences (GILD) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.
4 days ago · Gilead Sciences overview. Gilead Sciences (Gilead) is a research-based biopharmaceutical company. It carries out the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases such as hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, cancer, and human immunodeficiency virus ...
